Company Information for DYAX LTD
1 KINGDOM STREET, LONDON, W2 6BD,
|
Company Registration Number
![]() Private Limited Company
Active - Proposal to Strike off |
Company Name | |
---|---|
DYAX LTD | |
Legal Registered Office | |
1 KINGDOM STREET LONDON W2 6BD Other companies in EC2N | |
Company Number | 08965623 | |
---|---|---|
Company ID Number | 08965623 | |
Date formed | 2014-03-28 | |
Country | ENGLAND | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active - Proposal to Strike off | |
Lastest accounts | 31/12/2018 | |
Account next due | 30/09/2020 | |
Latest return | 28/03/2016 | |
Return next due | 25/04/2017 | |
Type of accounts | DORMANT |
Last Datalog update: | 2019-11-27 18:12:33 |
Companies House |
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
SHIRE CORPORATE SERVICES LIMITED |
||
DAMIEN RODOLPHE EDMOND BAILLY |
||
FEARGHAS MACGILP KERR CARRUTHERS |
||
JONATHAN IVAN WILLIAM WEBB |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
KETAN JAYSUKHLAL SEDANI |
Director | ||
SEBASTIAN STACHOWIAK |
Director | ||
HELEN ROSEMARY JANAWAY |
Director | ||
LESLEY SHARON ROCHE |
Director | ||
ANDREW D. ASHE |
Director | ||
GEORGE MIGAUSKY |
Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
NPS PHARMA UK LIMITED | Company Secretary | 2018-03-14 | CURRENT | 2006-11-13 | Active - Proposal to Strike off | |
SHIRE BIOPHARMACEUTICALS HOLDINGS | Company Secretary | 2018-03-13 | CURRENT | 2005-06-27 | Active - Proposal to Strike off | |
SHIRE GLOBAL FINANCE | Company Secretary | 2018-03-13 | CURRENT | 2005-04-08 | Active - Proposal to Strike off | |
SHIRE BIOTECH UK HOLDINGS LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2017-09-04 | Active - Proposal to Strike off | |
BAXALTA UK HOLDCO LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2014-10-03 | Active | |
BAXALTA UK LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2014-10-03 | Active - Proposal to Strike off | |
RYBAR LABORATORIES LIMITED | Company Secretary | 2018-03-01 | CURRENT | 1941-04-18 | Active - Proposal to Strike off | |
SHIRE PHARMACEUTICALS GROUP | Company Secretary | 2018-03-01 | CURRENT | 1994-01-01 | Active - Proposal to Strike off | |
SPARKLEFLAME LIMITED | Company Secretary | 2018-03-01 | CURRENT | 1995-10-17 | Active - Proposal to Strike off | |
SHIRE HOLDINGS EUROPE LIMITED | Company Secretary | 2018-03-01 | CURRENT | 1996-02-13 | Active - Proposal to Strike off | |
SHIRE HUMAN GENETIC THERAPIES UK LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2000-08-23 | Active - Proposal to Strike off | |
SHIRE HUMAN GENETIC THERAPIES LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2001-06-28 | Active - Proposal to Strike off | |
SHIRE PHARMACEUTICALS SERVICES LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2002-04-18 | Active - Proposal to Strike off | |
SHIRE HOLDINGS UK LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2003-02-14 | Active - Proposal to Strike off | |
SHIRE EUROPE FINANCE | Company Secretary | 2018-03-01 | CURRENT | 2004-07-30 | Active - Proposal to Strike off | |
SHIRE HOLDINGS UK CANADA LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2006-10-12 | Active - Proposal to Strike off | |
VIROPHARMA LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2007-05-14 | Active | |
SHIRE US INVESTMENTS | Company Secretary | 2018-03-01 | CURRENT | 2007-06-11 | Active - Proposal to Strike off | |
SHIRE EUROPE LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2008-04-10 | Active - Proposal to Strike off | |
BAXALTA UK INVESTMENTS LTD. | Company Secretary | 2018-03-01 | CURRENT | 2002-07-23 | Active - Proposal to Strike off | |
AURALIS LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2005-01-18 | Active - Proposal to Strike off | |
THE ENDOCRINE CENTRE LIMITED | Company Secretary | 2018-03-01 | CURRENT | 1991-04-22 | Active - Proposal to Strike off | |
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED | Company Secretary | 2018-03-01 | CURRENT | 1990-03-29 | Active - Proposal to Strike off | |
SHIRE PHARMACEUTICAL CONTRACTS LIMITED | Company Secretary | 2018-03-01 | CURRENT | 1986-06-02 | Active | |
SHIRE PHARMACEUTICALS LIMITED | Company Secretary | 2018-03-01 | CURRENT | 1986-06-26 | Active | |
MONMOUTH PHARMACEUTICALS LIMITED | Company Secretary | 2018-03-01 | CURRENT | 1984-04-17 | Active - Proposal to Strike off | |
SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY | Company Secretary | 2018-03-01 | CURRENT | 2001-12-20 | Liquidation | |
SHIRE UK INVESTMENTS LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2005-08-22 | Active - Proposal to Strike off | |
LUMENA PHARMA UK LIMITED | Company Secretary | 2018-03-01 | CURRENT | 2013-03-21 | Active - Proposal to Strike off | |
BAXALTA UK HOLDCO LIMITED | Director | 2018-01-15 | CURRENT | 2014-10-03 | Active | |
BAXALTA UK LIMITED | Director | 2018-01-15 | CURRENT | 2014-10-03 | Active - Proposal to Strike off | |
SHIRE PHARMACEUTICALS GROUP | Director | 2018-01-15 | CURRENT | 1994-01-01 | Active - Proposal to Strike off | |
BAXALTA UK INVESTMENTS LTD. | Director | 2018-01-15 | CURRENT | 2002-07-23 | Active - Proposal to Strike off | |
AURALIS LIMITED | Director | 2018-01-15 | CURRENT | 2005-01-18 | Active - Proposal to Strike off | |
SHIRE PHARMACEUTICAL CONTRACTS LIMITED | Director | 2018-01-15 | CURRENT | 1986-06-02 | Active | |
SHIRE PHARMACEUTICALS LIMITED | Director | 2018-01-15 | CURRENT | 1986-06-26 | Active | |
BAXALTA UK HOLDCO LIMITED | Director | 2017-12-31 | CURRENT | 2014-10-03 | Active | |
BAXALTA UK LIMITED | Director | 2017-12-31 | CURRENT | 2014-10-03 | Active - Proposal to Strike off | |
SHIRE PHARMACEUTICALS GROUP | Director | 2017-03-31 | CURRENT | 1994-01-01 | Active - Proposal to Strike off | |
SHIRE PHARMACEUTICALS SERVICES LIMITED | Director | 2017-03-31 | CURRENT | 2002-04-18 | Active - Proposal to Strike off | |
SHIRE HOLDINGS IRELAND | Director | 2013-05-20 | CURRENT | 2008-06-04 | Active | |
SHIRE HOLDINGS EUROPE LIMITED | Director | 2013-05-20 | CURRENT | 1996-02-13 | Active - Proposal to Strike off | |
SHIRE HOLDINGS UK LIMITED | Director | 2013-05-20 | CURRENT | 2003-02-14 | Active - Proposal to Strike off | |
SHIRE BIOPHARMACEUTICALS HOLDINGS | Director | 2013-05-20 | CURRENT | 2005-06-27 | Active - Proposal to Strike off | |
SHIRE HOLDINGS UK CANADA LIMITED | Director | 2013-05-20 | CURRENT | 2006-10-12 | Active - Proposal to Strike off | |
SHIRE US INVESTMENTS | Director | 2013-05-20 | CURRENT | 2007-06-11 | Active - Proposal to Strike off | |
SHIRE EUROPE LIMITED | Director | 2013-05-20 | CURRENT | 2008-04-10 | Active - Proposal to Strike off | |
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED | Director | 2013-05-20 | CURRENT | 1990-03-29 | Active - Proposal to Strike off | |
SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY | Director | 2013-05-20 | CURRENT | 2001-12-20 | Liquidation | |
SHIRE UK INVESTMENTS LIMITED | Director | 2013-05-20 | CURRENT | 2005-08-22 | Active - Proposal to Strike off | |
BAXALTA UK LIMITED | Director | 2017-11-30 | CURRENT | 2014-10-03 | Active - Proposal to Strike off | |
SHIRE BIOTECH UK HOLDINGS LIMITED | Director | 2017-09-04 | CURRENT | 2017-09-04 | Active - Proposal to Strike off | |
BAXALTA UK HOLDCO LIMITED | Director | 2017-02-24 | CURRENT | 2014-10-03 | Active | |
SHIRE HOLDINGS IRELAND | Director | 2016-11-01 | CURRENT | 2008-06-04 | Active |
Date | Document Type | Document Description |
---|---|---|
GAZ1(A) | FIRST GAZETTE notice for voluntary strike-off | |
DS01 | Application to strike the company off the register | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/18 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DAMIEN RODOLPHE EDMOND BAILLY | |
AP01 | DIRECTOR APPOINTED MR JONATHAN CLARK NEAL | |
CS01 | CONFIRMATION STATEMENT MADE ON 28/03/19, WITH NO UPDATES | |
PSC02 | Notification of Takeda Pharmaceutical Company Limited as a person with significant control on 2019-01-08 | |
PSC07 | CESSATION OF SHIRE PLC AS A PERSON OF SIGNIFICANT CONTROL | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/17 | |
AP01 | DIRECTOR APPOINTED MR MARK GIBBONS | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR FEARGHAS MACGILP KERR CARRUTHERS | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JONATHAN IVAN WILLIAM WEBB | |
CS01 | CONFIRMATION STATEMENT MADE ON 28/03/18, WITH NO UPDATES | |
AP04 | Appointment of Shire Corporate Services Limited as company secretary on 2018-03-01 | |
AP01 | DIRECTOR APPOINTED MR DAMIEN RODOLPHE EDMOND BAILLY | |
AP01 | DIRECTOR APPOINTED FEARGHAS MACGILP KERR CARRUTHERS | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR KETAN JAYSUKHLAL SEDANI | |
AP01 | DIRECTOR APPOINTED KETAN JAYSUKHLAL SEDANI | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR SEBASTIAN STACHOWIAK | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 31/12/16 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR HELEN ROSEMARY JANAWAY | |
AD04 | Register(s) moved to registered office address 1 Kingdom Street London W2 6BD | |
AD01 | REGISTERED OFFICE CHANGED ON 11/07/17 FROM Shire Lime Tree Way, Hampshire Int Business Park Chineham Basingstoke Hampshire RG24 8EP England | |
CH01 | Director's details changed for Jonathan Ivan William Webb on 2017-04-03 | |
LATEST SOC | 30/03/17 STATEMENT OF CAPITAL;GBP 1 | |
CS01 | CONFIRMATION STATEMENT MADE ON 28/03/17, WITH UPDATES | |
AD02 | SAIL ADDRESS CREATED | |
AD03 | REGISTER(S) MOVED TO SAIL ADDRESS 114-REG MEM 162-REG DIR 275-REG SEC 358-REC OF RES ETC REG PSC | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR SEBASTIAN STACHOWIAK / 03/01/2017 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MS HELEN ROSEMARY JANAWAY / 03/01/2017 | |
AP01 | DIRECTOR APPOINTED JONATHAN IVAN WILLIAM WEBB | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR LESLEY ROCHE | |
AA | ACCOUNTS OF DORMANT COMPANY MADE UP TO 31/12/15 | |
RES01 | ADOPT ARTICLES 04/04/2016 | |
LATEST SOC | 18/04/16 STATEMENT OF CAPITAL;GBP 1 | |
AR01 | 28/03/16 FULL LIST | |
AP01 | DIRECTOR APPOINTED MR SEBASTIAN STACHOWIAK | |
AP01 | DIRECTOR APPOINTED MS HELEN JANAWAY | |
AP01 | DIRECTOR APPOINTED MS LESLEY ROCHE | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR GEORGE MIGAUSKY | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ANDREW ASHE | |
AD01 | REGISTERED OFFICE CHANGED ON 15/04/2016 FROM ARNOLD & PORTER (UK) LLP TOWER 42 LEVEL 30 25 OLD BROAD STREET LONDON EC2N 1HQ | |
AA | ACCOUNTS OF DORMANT COMPANY MADE UP TO 31/12/14 | |
LATEST SOC | 08/04/15 STATEMENT OF CAPITAL;GBP 1 | |
AR01 | 28/03/15 FULL LIST | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / ESQ. ANDREW D. ASHE / 03/04/2015 | |
AA01 | CURRSHO FROM 31/03/2015 TO 31/12/2014 | |
LATEST SOC | 28/03/14 STATEMENT OF CAPITAL;GBP 1 | |
NEWINC | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max |
This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology
|
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on DYAX LTD
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as DYAX LTD are:
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |